or Try an Advanced Search...

    Sun Care Products Stocks List

    Symbol Grade Name % Change
    MRK A Merck & Company, Inc. 0.37
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major
    Related Stock Lists: Amines Animal Health Animal Health Products Antibiotics Cac 40 Constipation Diabetes Dow Jones Component Drug Wholesalers ETN Fertility Food Chain Foot Care Products Health Maintenance Organizations Health Products Health Solutions Infectious Diseases Life Sciences Lotion Medication

    Related ETFs - A few ETFs which own one or more of the above listed Sun Care Products stocks.

    Symbol Grade Name Weight
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 7.61
    PPH C Market Vectors Pharmaceutical ETF 6.31
    XLV C SPDR Select Sector Fund - Health Care 6.19
    PJP C PowerShares Dynamic Pharmaceuticals 6.0
    IYH C iShares U.S. Healthcare ETF 5.95
    View all Sun Care Products ETFs...
    Compare ETFs
    Compare FTXH to PJP Compare FTXH to PPH Compare PPH to IYH

        Sun Care Products Stocks Recent News

        Date Stock Title
        Apr 26 MRK Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points
        Apr 25 MRK Merck (MRK) Q1 2024 Earnings Call Transcript
        Apr 25 MRK Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
        Apr 25 MRK Merck & Co., Inc. (MRK) Q1 2024 Earnings Call Transcript
        Apr 25 MRK Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
        Apr 25 MRK Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
        Apr 25 MRK 20 Fastest Growing Health Tech Companies in the World
        Apr 25 MRK Merck raises 2024 guidance on cancer drug demand
        Apr 25 MRK Meta Falls 15% On Great Earnings, Tesla Rises 12% On Ugly Earnings – Here Is The Real Reason
        Apr 25 MRK Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
        Apr 25 MRK Merck raises guidance as Keytruda sales jump 20% in Q1
        Apr 25 MRK UPDATE 3-Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
        Apr 25 MRK Merck in charts: Pharmaceutical segment soars on KEYTRUDA, GARDASIL strength in Q1
        Apr 25 MRK Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
        Apr 25 MRK Merck Non-GAAP EPS of $2.07 beats by $0.15, revenue of $15.8B beats by $600M
        Apr 25 MRK Merck Announces First-Quarter 2024 Financial Results
        Apr 25 MRK Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
        Apr 25 MRK US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
        Apr 24 MRK Alphabet, Microsoft, Southwest earnings: What to watch
        Apr 24 MRK 4 Large Drug Stocks to Hold on to Amid Industry Challenges
        Related Industries: Drug Manufacturers - Major
        Related Stock Lists: Amines Animal Health Animal Health Products Antibiotics Cac 40 Constipation Diabetes Dow Jones Component Drug Wholesalers ETN Fertility Food Chain Foot Care Products Health Maintenance Organizations Health Products Health Solutions Infectious Diseases Life Sciences Lotion Medication
        Sun Care Products

        Browse All Tags